Biotech NewsDenali Therapeutics (DNLI) Crashes 8.3% Premarket After Pricing $200M Offering BioTech Health XDecember 10, 2025 Denali Therapeutics Inc (NASDAQ:DNLI) is a biotechnology company founded with the mission to confront some of the most… 0 Shares 0 0 0 0 0 0 0